Skip to content

Q3 FY24 Earnings Results

Q3 FY24 earnings, Oct–Dec 2023: 4,775 Indian listed companies have reported; median profit growth is +4.1% on last year. Quarter ended 31 Dec 2023.

Clear filters 1–100 of 215
CompanyRevenue (₹ Cr)Profit (₹ Cr)Per share8Q profit
Symbol Sector Reported YoY QoQ Reported YoY EPS vs consensus Trend
SUNPHARMA Sun Pharmaceutical Industries LtdHealthcare12,381n/aup+1.6%2,561n/a10.52No estimate
AUROPHARMA Aurobindo Pharma LtdHealthcare7,352n/aup+1.8%940n/a15.98No estimate
DRREDDY Dr Reddys Laboratories LtdHealthcare7,237n/aup+4.8%1,381n/a16.56No estimate
CIPLA Cipla LtdHealthcare6,604n/adown−1.1%1,068n/a13.08No estimate
LUPIN Lupin LtdHealthcare5,197n/aup+3.1%619n/a13.47No estimate
ZYDUSLIFE Zydus Lifesciences LtdHealthcare4,505n/aup+3.1%790n/a7.80No estimate
BIOCON Biocon LtdHealthcare3,954n/aup+14.2%753n/a5.50No estimate
ALKEM Alkem Laboratories LtdHealthcare3,324n/adown−3.4%604n/a49.76No estimate
TORNTPHARM Torrent Pharmaceuticals LtdHealthcare2,732n/aup+2.7%443n/a13.09No estimate
MANKIND Mankind Pharma LtdHealthcare2,607n/adown−3.7%460n/a11.33No estimate
GLENMARK Glenmark Pharmaceuticals LtdHealthcare2,507n/adown−21.8%−331n/a−12.45No estimate
IPCALAB Ipca Laboratories LtdHealthcare2,053n/aup+0.9%221n/a7.09No estimate
PPLPHARMA Piramal Pharma LtdHealthcare1,959n/aup+2.5%10n/a0.08No estimate
DIVISLAB Divis Laboratories LtdHealthcare1,855n/adown−2.8%358n/a13.49No estimate
JUBLPHARMA Jubilant Pharmova LtdHealthcare1,677n/adown−0.2%66n/a4.19No estimate
EMCURE Emcure Pharmaceuticals LtdHealthcare1,668n/aup+0.3%120n/a6.27No estimate
APLLTD Alembic Pharmaceuticals LtdHealthcare1,631n/aup+2.3%180n/a9.18No estimate
GLAND Gland Pharma LtdHealthcare1,545n/aup+12.5%192n/a11.65No estimate
ABBOTINDIA Abbott India LtdHealthcare1,437n/adown−3.8%311n/a146.35No estimate
LAURUSLABS Laurus Labs LtdHealthcare1,195n/adown−2.4%23n/a0.43No estimate
GRANULES Granules India LtdHealthcare1,156n/adown−2.8%126n/a5.18No estimate
AJANTPHARM Ajanta Pharma LtdHealthcare1,105n/aup+7.5%210n/a16.39No estimate
AKUMS Akums Drugs & Pharmaceuticals LtdHealthcare1,083n/adown−8.3%195n/a13.54No estimate
STAR Strides Pharma Science LtdHealthcare1,006n/aup+0.7%54n/a5.40No estimate
SYNGENE Syngene International LtdHealthcare854n/adown−6.2%112n/a2.77No estimate
JBCHEPHARM J B Chemicals & Pharmaceuticals LtdHealthcare845n/adown−4.2%134n/a8.62No estimate
GLAXO Glaxosmithkline Pharmaceuticals LtdHealthcare805n/adown−15.9%46n/a2.70No estimate
NATCOPHARM Natco Pharma LtdHealthcare759n/adown−26.4%213n/a10.84No estimate
WOCKPHARMA Wockhardt LtdHealthcare701n/adown−6.9%−86n/a−5.76No estimate
INDGN Indegene LtdHealthcare673n/aup+5.8%99n/a4.45No estimate
DCAL Dishman Carbogen Amcis LtdHealthcare651n/aup+10.9%−60n/a−3.80No estimate
AARTIDRUGS Aarti Drugs LtdHealthcare606n/adown−5.6%37n/a3.99No estimate
MARKSANS Marksans Pharma LtdHealthcare586n/aup+10.4%83n/a1.84No estimate
ALIVUS Alivus Life Sciences LtdHealthcare573n/adown−3.7%119n/a9.69No estimate
PFIZER Pfizer LtdHealthcare540n/adown−6.1%130n/a28.41No estimate
IOLCP IOL Chemicals & Pharmaceuticals LtdHealthcare520n/adown−4.6%23n/a0.79No estimate
ERIS ERIS Lifesciences LtdHealthcare486n/adown−3.8%101n/a7.55No estimate
SANOFI Sanofi India LtdHealthcare469n/adown−4.5%138n/a59.87No estimate
UNICHEMLAB Unichem Laboratories LtdHealthcare466n/aup+12.0%73n/a10.40No estimate
INDOCO Indoco Remedies LtdHealthcare459n/adown−4.8%16n/a1.77No estimate
FDC FDC LtdHealthcare458n/adown−5.8%79n/a4.87No estimate
NECLIFE Nectar Lifescience LtdHealthcare452n/aup+13.6%2n/a0.07No estimate
AARTIPHARM Aarti Pharmalabs LtdHealthcare449n/aup+2.0%53n/a5.82No estimate
HIKAL Hikal LtdHealthcare448n/aup+2.9%16n/a1.31No estimate
MOREPENLAB Morepen Laboratories LtdHealthcare445n/aup+5.5%32n/a0.63No estimate
CAPLIPOINT Caplin Point Laboratories LtdHealthcare436n/aup+6.3%120n/a15.43No estimate
NEULANDLAB Neuland Laboratories LtdHealthcare393n/adown−6.0%81n/a63.44No estimate
SAILIFE Sai Life Sciences LtdHealthcare384n/an/a40n/a—No estimate
POLYMED Poly Medicure LtdHealthcare340n/aup+0.9%65n/a6.78No estimate
VIYASH Viyash Scientific LtdHealthcare329n/adown−4.9%11n/a0.33No estimate
PGHL Procter & Gamble Health LtdHealthcare310n/aup+1.6%72n/a43.42No estimate
ASTRAZEN Astrazeneca Pharma India LtdHealthcare306n/adown−1.6%16n/a6.32No estimate
INNOVACAP Innova Captab LtdHealthcare302n/aup+6.7%25n/a4.39No estimate
INDSWFTLAB Ind-Swift Laboratories LtdHealthcare288n/adown−0.7%19n/a3.29No estimate
SHILPAMED Shilpa Medicare LtdHealthcare287n/adown−8.3%5n/a0.26No estimate
CONCORDBIO Concord Biotech LtdHealthcare241n/adown−8.0%75n/a7.13No estimate
SANOFICONR Sanofi Consumer Healthcare India LtdHealthcare225n/aup+7.1%68n/a—No estimate
ORCHPHARMA Orchid Pharma LtdHealthcare221n/aup+11.0%29n/a5.80No estimate
COHANCE Cohance Lifesciences LtdHealthcare220n/adown−4.8%47n/a1.84No estimate
SOLARA Solara Active Pharma Sciences LtdHealthcare212n/adown−50.1%−275n/a−57.36No estimate
GUFICBIO Gufic BioSciences LtdHealthcare202n/adown−6.0%22n/a2.22No estimate
BLISSGVS Bliss GVS Pharma LtdHealthcare201n/adown−5.2%29n/a2.64No estimate
BI Bilcare LtdHealthcare175n/adown−7.9%−14n/a−2.91No estimate
ANUHPHR Anuh Pharma LtdHealthcare172n/aup+14.7%19n/a1.91No estimate
BLUEJET Blue Jet Healthcare LtdHealthcare167n/adown−7.7%32n/a1.85No estimate
ACUTAAS Acutaas Chemicals LtdHealthcare166n/adown−3.5%18n/a2.27No estimate
WINDLAS Windlas Biotech LtdHealthcare162n/aup+5.9%15n/a7.26No estimate
ADVENZYMES Advanced Enzyme Technologies LtdHealthcare161n/aup+1.9%42n/a3.74No estimate
SMSPHARMA SMS Pharmaceuticals LtdHealthcare161n/adown−3.6%11n/a1.36No estimate
KOPRAN Kopran LtdHealthcare159n/aup+4.1%16n/a3.28No estimate
RPGLIFE RPG Life Sciences LtdHealthcare154n/a0.0%26n/a16.00No estimate
PANACEABIO Panacea Biotec LtdHealthcare151n/aup+5.2%−2n/a−0.37No estimate
LINCOLN Lincoln Pharmaceuticals LtdHealthcare146n/adown−6.4%28n/a14.00No estimate
WANBURY Wanbury LtdHealthcare146n/aup+0.7%10n/a3.14No estimate
VENUSREM Venus Remedies LtdHealthcare143n/adown−14.9%7n/a5.12No estimate
SUPRIYA Supriya Lifescience LtdHealthcare140n/a0.0%30n/a3.70No estimate
Brabourne Enterprises Ltd(merged) Healthcare126n/an/a43n/a41.41No estimate
AMRUTANJAN Amrutanjan Health Care LtdHealthcare117n/aup+17.8%17n/a6.04No estimate
Emergy Phaarma Ltd Healthcare115up+26.6%down−19.2%−44down−566.5%−42.18No estimate
SIGACHI Sigachi Industries LtdHealthcare111n/aup+11.9%16n/a0.50No estimate
BAJAJHCARE Bajaj Healthcare LtdHealthcare109n/aup+7.9%−2n/a−0.80No estimate
Tonira Pharma Ltd(merged) Healthcare106up+7.1%up+2.9%16up+6.7%2.36No estimate
INDSWFTLTD Ind-Swift Ltd(Merged)Healthcare103down−3.7%down−11.2%−15n/a−2.76No estimate
FERMENTA Fermenta Biotech LtdHealthcare99n/aup+73.9%10n/a3.35No estimate
MANGALAM Mangalam Drugs and Organics LtdHealthcare97n/aup+19.3%1n/a0.32No estimate
ZIMLAB Zim Laboratories LtdHealthcare96n/aup+12.2%5n/a0.98No estimate
ALBERTDAVD Albert David LtdHealthcare88n/adown−5.4%19n/a32.80No estimate
FREDUN Fredun Pharmaceuticals LtdHealthcare87n/aup+6.1%4n/a2.99No estimate
NGLFINE NGL Fine Chem LtdHealthcare85n/aup+7.6%9n/a14.41No estimate
NOVARTIND Novartis India LtdHealthcare85n/aup+7.6%27n/a10.76No estimate
THEMISMED Themis Medicare LtdHealthcare83n/adown−21.0%7n/a0.80No estimate
Anus Laboratories Ltd Healthcare82down−56.1%up+355.6%50up+47.1%2.35No estimate
BALPHARMA Bal Pharma LtdHealthcare82n/adown−11.8%1n/a0.56No estimate
SENORES Senores Pharmaceuticals LtdHealthcare79n/an/a7n/a2.37No estimate
KPL Kwality Pharmaceuticals LtdHealthcare78n/aup+11.4%8n/a7.41No estimate
AAREYDRUGS Aarey Drugs & Pharmaceuticals LtdHealthcare76n/aup+32.2%1n/a0.40No estimate
VIMTALABS Vimta Labs LtdHealthcare73n/aup+14.1%9n/a2.14No estimate
HALEOSLABS Haleos Labs LimitedHealthcare72n/aup+4.0%4n/a14.22No estimate
HESTERBIO Hester Biosciences LtdHealthcare67n/adown−4.3%4n/a4.68No estimate
SYNCOMF Syncom Formulations (India) LtdHealthcare63n/aup+1.6%6n/a0.07No estimate

About Q3 FY24 earnings data

When are Q3 FY24 results announced?
Q3 FY24 covers the Oct–Dec 2023 quarter. Indian listed companies have up to 45 days after a quarter closes to file their results — 60 days for the January–March quarter — so results arrive in a wave over the weeks that follow rather than all at once. A quarter that has only just ended will look sparse and fill in.
Why do some Q3 FY24 growth figures show "n/a" instead of a percentage?
Growth is left blank whenever the comparison period was not profitable. A percentage change measured from a loss is arithmetic without meaning — a swing from a ₹10 crore loss to a ₹10 crore profit is not "200% growth", and publishing it as such would flatter the company. The reported figures for both periods are still shown, so the change is there to read directly.
Does the beat/miss verdict cover every company?
No analyst consensus was available for Q3 FY24, so no beat/miss verdict is shown. Revenue and profit growth are taken from reported results and cover every company in the table.
What counts as an in-line result rather than a beat or a miss?
Reported earnings per share within ±2% of the consensus estimate. The band is set there because a tighter one classifies rounding as news, and a wider one swallows surprises that genuinely moved a stock.
Are the figures consolidated or standalone?
Consolidated where a company reports on that basis, standalone otherwise, with all money in ₹ crore. Figures are as filed by the company with the exchanges (NSE/BSE); they are not restated or adjusted.
What does the 8-quarter trend line show?
Quarterly net profit for the last eight quarters, oldest on the left, always ending on the quarter shown in the row. Two years covers both the seasonal shape of the business and its direction. The line breaks where a quarter is missing rather than drawing across the gap, so a break is a real absence of data and not a reported collapse.
How do I find only the companies that beat estimates in Q3 FY24?
Use the Result filter above the table and choose Beat, or sort by EPS surprise to rank every covered company by how far it landed from consensus. Both are reflected in the page URL, so a filtered view can be bookmarked or shared.

Figures are as reported by companies in their quarterly filings to the exchanges (NSE/BSE), in ₹ crore. Consolidated results are shown where a company reports them, otherwise standalone. Year-on-year and quarter-on-quarter growth is omitted where the comparison period was loss-making, since a percentage change from a negative base is not meaningful. Analyst consensus is an estimate, not a forecast of outcome.